State of Alaska Department of Revenue’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.7M Buy
138,276
+47,012
+52% +$577K 0.02% 788
2025
Q1
$2.01M Sell
91,264
-40,127
-31% -$882K 0.02% 674
2024
Q4
$2.98M Sell
131,391
-360
-0.3% -$8.16K 0.03% 498
2024
Q3
$2.39M Buy
131,751
+77,825
+144% +$1.41M 0.03% 653
2024
Q2
$1.57M Buy
53,926
+32,726
+154% +$953K 0.02% 773
2024
Q1
$750K Hold
21,200
0.01% 1194
2023
Q4
$922K Sell
21,200
-895
-4% -$38.9K 0.01% 1049
2023
Q3
$843K Sell
22,095
-410
-2% -$15.6K 0.01% 1042
2023
Q2
$925K Sell
22,505
-1,172
-5% -$48.2K 0.01% 1024
2023
Q1
$1.36M Sell
23,677
-75
-0.3% -$4.31K 0.02% 825
2022
Q4
$1.33M Buy
23,752
+262
+1% +$14.7K 0.02% 816
2022
Q3
$994K Buy
23,490
+13,214
+129% +$559K 0.01% 917
2022
Q2
$555K Sell
10,276
-110
-1% -$5.94K 0.01% 1309
2022
Q1
$667K Sell
10,386
-160
-2% -$10.3K 0.01% 1249
2021
Q4
$706K Sell
10,546
-15,379
-59% -$1.03M 0.01% 1277
2021
Q3
$1.77M Buy
25,925
+14,896
+135% +$1.02M 0.02% 770
2021
Q2
$752K Sell
11,029
-75
-0.7% -$5.11K 0.01% 1244
2021
Q1
$767K Sell
11,104
-398
-3% -$27.5K 0.01% 1216
2020
Q4
$746K Sell
11,502
-563
-5% -$36.5K 0.01% 1130
2020
Q3
$569K Sell
12,065
-457
-4% -$21.6K 0.01% 1169
2020
Q2
$588K Buy
12,522
+266
+2% +$12.5K 0.01% 1159
2020
Q1
$547K Buy
12,256
+540
+5% +$24.1K 0.01% 1062
2019
Q4
$682K Sell
11,716
-907
-7% -$52.8K 0.01% 1141
2019
Q3
$758K Buy
12,623
+4,494
+55% +$270K 0.01% 1039
2019
Q2
$453K Buy
8,129
+15
+0.2% +$836 0.01% 1112
2019
Q1
$451K Sell
8,114
-348
-4% -$19.3K 0.01% 1115
2018
Q4
$381K Buy
8,462
+81
+1% +$3.65K 0.01% 1121
2018
Q3
$551K Buy
8,381
+1,571
+23% +$103K 0.01% 1038
2018
Q2
$438K Sell
6,810
-13,709
-67% -$882K 0.01% 1163
2018
Q1
$1.14M Buy
20,519
+7,850
+62% +$434K 0.02% 645
2017
Q4
$606K Buy
12,669
+180
+1% +$8.61K 0.01% 732
2017
Q3
$630K Buy
12,489
+550
+5% +$27.7K 0.03% 621
2017
Q2
$650K Buy
11,939
+5,309
+80% +$289K 0.04% 326
2017
Q1
$279K Buy
6,630
+170
+3% +$7.15K 0.02% 516
2016
Q4
$277K Buy
+6,460
New +$277K 0.03% 348